文献速递关节外科创伤骨科

七日关节内抗生素冲洗治疗慢性假体周围关节感染的安全性:一项前瞻性随机II期对照研究

Safety Profile of Seven-Day Intra-articular Antibiotic Irrigation for the Treatment of Chronic Periprosthetic Joint Infection: A Prospective Randomized Phase II Comparative Study.
PubMed 文献 · J Arthroplasty · 2024-04-09

这项II期多中心前瞻性随机对照试验评估快速七日两阶段翻修联合关节内抗生素冲洗(实验组37例)与标准两阶段翻修(对照组39例)的安全性。结果显示无抗生素药物相关不良事件,万古霉素和妥布霉素血清峰浓度均低于最大可接受阈值,两组输血量无差异。结论认为关节内抗生素冲洗全身暴露极少、安全性良好,疗效正在进一步研究中。

要点

  • 实验组采用妥布霉素80 mg每日冲洗浸泡2小时,继以万古霉素125 mg每小时冲洗浸泡30分钟。
  • 188次万古霉素峰浓度中69%可检出,所有浓度均低于最大可接受谷浓度阈值20 μg/mL。
  • 103次妥布霉素峰浓度中45%可检出,所有浓度均低于最大可接受峰浓度阈值18至24 μg/mL。

核心结论

  • 作者认为关节内抗生素冲洗安全性良好,全身抗生素暴露极少。
  • 两组严重不良事件的发生率或严重程度无差异。
  • 作者指出正在进一步研究以考察治疗疗效。

研究设计与样本

  • II期、多中心、前瞻性随机对照试验,评估快速七日两阶段翻修联合关节内抗生素冲洗与标准两阶段翻修的安全性。
  • 实验组37例,对照组39例随机分配,两组基线人口学特征或合并症无差异。
  • 实验组经髓内冲洗装置给予妥布霉素80 mg每日浸泡2小时,继以万古霉素125 mg每小时冲洗浸泡30分钟。
  • 对照组使用载万古霉素(平均8.4 g)和妥布霉素(平均7.1 g,抗生素总量16 g)的骨水泥间隔物。
  • 两组在第二阶段术后均接受12周全身抗生素治疗。

主要发现

  • 无抗生素药物相关不良事件,发生2例与抗生素灌注相关的严重不良事件。
  • 188次万古霉素峰浓度测量中69%可检出,所有浓度均远低于最大可接受谷浓度阈值20 μg/mL。
  • 103次妥布霉素峰浓度测量中45%可检出,所有浓度均低于最大可接受峰浓度阈值18至24 μg/mL。
  • 每例受试者输血量无差异(实验组655 mL vs 对照组792 mL,P = .4188)。
  • 实验组死亡2例,对照组死亡4例。

关键数值与推荐

  • 实验组妥布霉素用法为80 mg每日,浸泡2小时。
  • 实验组万古霉素用法为125 mg每小时,浸泡30分钟。
  • 万古霉素最大可接受谷浓度阈值为20 μg/mL。
  • 妥布霉素最大可接受峰浓度阈值为18至24 μg/mL。
  • 对照组骨水泥间隔物含万古霉素平均8.4 g和妥布霉素平均7.1 g,抗生素总量16 g。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出正在进一步研究以考察治疗疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Systemic intravenous antimicrobials yield poor outcomes during treatment of periprosthetic joint infection due to the inability to obtain minimum biofilm eradication concentrations. This study evaluated the safety of a novel method of optimized local delivery of intra-articular antibiotics (IAAs). METHODS: This was a Phase II, multicenter, prospective randomized trial evaluating safety of a rapid (seven-day) two-stage exchange arthroplasty with IAA irrigation compared to standard two-stage exchange. The Experimental Group received irrigation using 80 mg tobramycin daily with a 2-hour soak, followed by hourly irrigation using 125 mg vancomycin with a 30-minute soak via an intramedullary irrigation device. The Control Group received an antibiotic-loaded cement spacer with vancomycin (average 8.4 g) and tobramycin (average 7.1 g, total 16 g antibiotics). Both groups received 12 weeks of systemic antibiotics following Stage 2. Safety measures included adverse events, peak vancomycin/tobramycin serum concentrations (Experimental Group), blood transfusion, and mortality. There were thirty-seven patients randomized to the Experimental Group and 39 to control. There was no difference in baseline demographics or comorbidities. RESULTS: There were no antibiotic medication-related adverse events and 2 serious adverse events related to antibiotic instillation. Of 188 vancomycin peak measurements, 69% had detectable serum level concentrations, with all concentrations well below the maximum acceptable trough threshold of 20 μg/mL. Of the 103 tobramycin peak measurements, 45% had detectable levels, with all below the maximum acceptable peak threshold of 18 to 24 μg/mL. There was no difference in blood transfused per subject (Experimental: 655 mL versus Control: 792 mL; P = .4188). There were two (2) deaths in the Experimental Group and four (4) in the control. CONCLUSIONS: The use of IAA is safe with minimal systemic antibiotic exposure. There was no difference in the rates or severity of serious adverse events between groups. Further research is being conducted to examine treatment efficacy.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Springer BD, Higuera-Rueda CA, de Beaubien BC, et al. Safety Profile of Seven-Day Intra-articular Antibiotic Irrigation for the Treatment of Chronic Periprosthetic Joint Infection: A Prospective Randomized Phase II Comparative Study. J Arthroplasty. 2024. PMID: 38604274. doi:10.1016/j.arth.2024.03.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。